Ovarian Cancer Research Alliance (OCRA) is the largest non-government funder of ovarian cancer research and has invested $122 million in research. OCRA fights ovarian cancer from all fronts, including in the lab and on Capitol Hill, and through innovative programs to support survivors and their families.

OCRA’s ongoing commitment to the most promising scientific research is funding discoveries, creating new treatments, and hastening desperately needed breakthroughs. We are the voice for the ovarian cancer community, working with legislators to ensure federal ovarian cancer research and education, patient safety, and access to high-quality care are protected on Capitol Hill. Our programs help women navigate their diagnosis and support patients and their families when and where they need it most.

Visit ocrahope.org to learn more.